Cost-Effectiveness Analysis for the Treatment of Hyperphosphatemia in Predialysis Patients: Calcium-Based versus Noncalcium-Based Phosphate Binders

about

Cost-Effectiveness Analysis for the Treatment of Hyperphosphatemia in Predialysis Patients: Calcium-Based versus Noncalcium-Based Phosphate Binders

Item

http://www.wikidata.org/entity/Q57492952

description

scientific article published on 19 September 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Cost-Effectiveness Analysis fo ...... alcium-Based Phosphate Binders

@en

Cost-Effectiveness Analysis fo ...... alcium-Based Phosphate Binders

@nl

type

Item

label

Cost-Effectiveness Analysis fo ...... alcium-Based Phosphate Binders

@en

Cost-Effectiveness Analysis fo ...... alcium-Based Phosphate Binders

@nl

prefLabel

Cost-Effectiveness Analysis fo ...... alcium-Based Phosphate Binders

@en

Cost-Effectiveness Analysis fo ...... alcium-Based Phosphate Binders

@nl

P1476

Cost-Effectiveness Analysis fo ...... alcium-Based Phosphate Binders

@en

P2093

A Goh

http://www.w3.org/2001/XMLSchema#string

A Soraya

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence of chronic kidney disease in population-based studies: systematic review

Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis

Phosphate - the silent stealthy cardiorenal culprit in all stages of chronic kidney disease: a systematic review.

Chronic kidney disease: global dimension and perspectives.

Investigating diet and physical activity in Malaysia: education and family history of diabetes relate to lower levels of physical activity

Chronic kidney disease progression and outcome according to serum phosphorus in mild-to-moderate kidney dysfunction

KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

Trends in prevalence of diabetes in Asian countries.

Sevelamer is cost-saving vs. calcium carbonate in non-dialysis-dependent CKD patients in italy: a patient-level cost-effectiveness analysis of the INDEPENDENT study.

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients.

P304

2138528

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2018/2138528

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2018

http://www.w3.org/2001/XMLSchema#string

P50

Bak Leong Goh

K L Ang

P577

2018-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30327732

http://www.w3.org/2001/XMLSchema#string

P921

nephrology

P932

6169205

http://www.w3.org/2001/XMLSchema#string